Lauding the scientists and technicians for the #39;Made in India #39; vaccines, Prime Minister Narendra Modi said the country is proud of them.
Tag: Coronavirus in India
-
‘Every Indian proud’: PM Modi lauds emergency approval of SII and Bharat Biotech’s Covid vaccines
By Online Desk
Soon after Drugs Controller General of India (DCGI) approved Serum Institute of India (SII) and Bharat Biotecth’s COVID-19 vaccine for emergency use, Prime Minister Narendra Modi took to Twitter to call the development a ‘decisive turning point to strengthen a spirited fight’, against coronavirus.PM Modi, in a tweet, said “DCGI granting approval to vaccines of @SerumInstIndia and @BharatBiotech accelerates the road to a healthier and COVID-free nation. Congratulations India. Congratulations to our hardworking scientists and innovators.”
He further added that, every Indian would be proud of the fact that two India made vaccines have been given emergency use approval.
#BREAKING | A very happy new year indeed! India’s drug controller has approved #Covaxin and #Covishield for emergency use in the country.#Covid19vaccine #CovidVaccine pic.twitter.com/QQWMzWufxs
— The New Indian Express (@NewIndianXpress) January 3, 2021Earlier on Saturday, the Subject Expert Committee (SEC) of the Central Drugs Standards Control Organisation made recommendations to the DCGI to grant permission for restricted emergency use of SII and Bharat Biotech’s ‘Covishield’ and ‘Covaxin’ vaccines respectively.
The PM further said ‘We reiterate our gratitude to doctors, medical staff, scientists, police personnel, sanitation workers and all Corona warriors for the outstanding work done, that too in adverse circumstances.’
‘Covaxin’ is an indigenously developed coronavirus vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
We reiterate our gratitude to doctors, medical staff, scientists, police personnel, sanitation workers and all Corona warriors for the outstanding work done, that too in adverse circumstances. We will remain eternally grateful to them for saving many lives.
— Narendra Modi (@narendramodi) January 3, 2021While the Serum Institute of India, the world’s largest vaccine manufacturer, has tied up with AstraZeneca to manufacture ‘Covishield’.
(Inputs from PTI, ANI)
-
18,177 fresh cases in 24 hours take India’s coronavirus tally to 1,03,23,965
By PTI
NEW DELHI: India recorded 18,177 new COVID-19 cases cases in a day, while 99,27,310 people have recuperated so far pushing the national recovery rate to 96.15 per cent on Sunday, according to the Union Health Ministry data.The total coronavirus cases mounted to 1,03,23,965 and the death toll climbed to 1,49,435 with the novel coronavirus virus claiming 217 lives in a span of 24 hours in the country, the data updated at 8.00 am showed.
ALSO READ | Drugs Controller General of India to brief media on COVID-19 vaccine update
The COVID-19 case fatality rate stood at 1.45 per cent.
There are 2,47,220 active cases of coronavirus infection in the country which comprises 2.39 per cent of the total caseload, the data stated.
According to the ICMR, a cumulative total of 17,48,99,783 samples have been tested up to January 2 with 9,58,125 samples being tested on Saturday.
ALSO WATCH: